TP53 and breast carcinoma: Our study sought to understand the heterogeneous characteristics of breast cancer cases in a cohort with regards to histopathologic features, morphologic growth patterns and clinical behaviours [25] and immunohistochemical expression pattern of p53 and MDM2 [26].